等待開盤 12-19 09:30:00 美东时间
+1.400
+1.06%
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
12-15 15:30
Barclays analyst Benjamin Budish maintains KKR (NYSE:KKR) with a Overweight and raises the price target from $154 to $169.
12-13 04:19
https://media.kkr.com/news-details?news_id=2e27aaca-3907-467e-89ad-a4e2740c1f0e
12-13 02:13
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
12-12 10:24
KKR (NYSE:KKR) has outperformed the market over the past 5 years by 14.57% on a...
12-10 00:45
Capital Group and KKR expand partnership to develop retirement and wealth products combining public and private investments.
12-04 01:12
Global investment firm KKR and Lighthouse Learning Group ("Lighthouse Learning"), a leading Indian education services provider, today announced an investment by funds managed by KKR alongside participation from a new
11-25 17:34
Andreas Halvorsen of Viking Global Investors' portfolio Q3 changes included exits from Amazon, Nvidia and Qualcomm.
11-18 00:19
KKR (NYSE:KKR) has outperformed the market over the past 15 years by 3.94% on a...
11-15 06:00
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43